Clinical Trials on Serous Ovarian Cancer
Total 137809 results
-
Karolinska InstitutetSkane University HospitalActive, not recruitingAdvanced Ovarian CancerSweden
-
Hoffmann-La RocheCompletedOVARIAN CANCERItaly, Spain, United States
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetic Laboratories, Inc.CompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Italy, Spain, Belgium, Poland, Canada, Korea, Republic of, Brazil, Czechia, Hungary, Israel, Argentina, Mexico
-
Eisai Inc.CompletedPlatinum-Sensitive Ovarian Cancer in First RelapseUnited States, Italy, United Kingdom, Germany, Spain, Belgium, Japan
-
Lei LiUnknownEpithelial Ovarian Cancer | Metabolomics | Transcriptomics | Whole Exome Sequencing | Tumor Invasiveness | TumorigenesisChina
-
National Cancer Institute (NCI)CompletedCervical Cancer | Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
AmgenTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerUnited States, Belgium, Germany, Italy, United Kingdom, Canada, Denmark, Switzerland, Hong Kong, Austria, Slovakia, Taiwan, Hungary, France, Singapore, Australia, Poland, New Zealand
-
AmgenCompletedCarcinoma | Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumors | Oncology | Tumors | Metastases | Gynecological MalignanciesBelgium, United States, Australia
-
Floyd & Delores Jones Cancer Institute at Virginia...CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingProgressive Disease | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Carcinoma | Endometrial Adenocarcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Platinum-Resistant Ovarian Carcinoma | High Grade Ovarian... and other conditionsUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingAdvanced Endometrial Cancer, Cervical Cancer and Ovarian CancerChina
-
National Cancer Institute, NaplesActive, not recruiting
-
M.D. Anderson Cancer CenterTerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Donna Hammond, PhDNational Cancer Institute (NCI); ChromaDex, Inc.TerminatedBreast Cancer Metastatic | Chemotherapy-induced Peripheral Neuropathy | Head and Neck Cancer Stage IV | Endometrial Cancer Stage IV | Platinum-resistant Recurrent Ovarian CancerUnited States
-
University of California, San FranciscoRadiological Society of North AmericaCompletedOvarian CarcinomaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Celldex TherapeuticsRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Serous Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Platinum-Sensitive Ovarian Carcinoma | Recurrent Fallopian... and other conditionsUnited States
-
Kaohsiung Medical University Chung-Ho Memorial...RecruitingOvarian Cancer | Lung Cancer | Brain Tumor | Liver CancerTaiwan
-
Tesaro, Inc.Completed
-
EMD SeronoWithdrawn
-
Assistance Publique - Hôpitaux de ParisTerminatedOvarian Cancer | RelapsesFrance
-
Jonsson Comprehensive Cancer CenterTetraLogic Pharmaceuticals; California Institute for Regenerative Medicine... and other collaboratorsWithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | High Grade Ovarian Serous Adenocarcinoma | High Grade Fallopian Tube Serous AdenocarcinomaUnited States
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedOvarian CancerBelgium, United States, United Kingdom
-
M.D. Anderson Cancer CenterCompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)TerminatedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterNew York University; Hadassah Medical Organization; New York Presbyterian Hospital and other collaboratorsCompletedBreast Cancer | Ovarian CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownOvarian Cancer | Fallopian Tube CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Seromucinous Carcinoma | Recurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Fallopian Tube Mucinous Adenocarcinoma | Recurrent Fallopian Tube Clear Cell Adenocarcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
Institut Mutualiste MontsourisMauna Kea TechnologiesCompletedFeasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE) (PERSEE)Ovarian Cancer | Cancer of Digestive SystemFrance
-
Cancer Research UKActive, not recruitinga. Colorectal Cancer | b. High Grade Serous Ovarian Cancer | c. Non Small-cell Lung Cancer (Squamous Cell Variant) | d. Squamous Carcinoma of the Oesophagus | e. Squamous Carcinoma of the Head and Neck (HPV Negative) | f. Urothelial Cancer | g. Breast Cancer (Triple Negative Type) | h. Pancreatic...United Kingdom
-
Kancera ABNordic Society of Gynaecological Oncology - Clinical Trials UnitRecruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerDenmark, Norway, Sweden
-
Cordgenics, LLCActive, not recruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian CancerUnited States
-
AkesoTerminatedOvarian Neoplasms | Ovarian Cancer | Recurrent Ovarian Carcinoma | Relapsed Ovarian CancerChina
-
Royal Surrey County Hospital NHS Foundation TrustUniversity of Surrey; Target Ovarian CancerUnknownPeritoneal Diseases | Ovarian Neoplasms | Peritoneal Neoplasms | Ovarian Cancer | Abdominal Neoplasm | Bowel Obstruction | Primary Peritoneal Carcinoma | Metastatic Ovarian Cancer | Ovarian DiseaseUnited Kingdom
-
Grupo Español de Investigación en Cáncer de OvarioAstraZeneca; Apices Soluciones S.L.Completed
-
The Christie NHS Foundation TrustNovartis; East and North Hertfordshire NHS Trust; Mateon TherapeuticsTerminatedOvarian Neoplasms | Ovarian Cancer | Neoplasms, OvarianUnited Kingdom
-
Women and Infants Hospital of Rhode IslandOrtho Biotech, Inc.Terminated
-
Sutro Biopharma, Inc.Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Ovarian Carcinoma | Endometrioid Adenocarcinoma | Ovary Cancer | Primary Peritoneal CarcinomaUnited States, Spain
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceActive, not recruitingOvarian Cancer | Endometrial CancerFrance
-
Imperial College LondonGlaxoSmithKlineCompletedOvarian NeoplasmUnited Kingdom
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompletedOvarian CancerGreece
-
858 Therapeutics, Inc.RecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Advanced or Metastatic Solid Tumors | ER+ Breast Cancer | Castrate Resistant Prostate Cancer | BRCA MutationUnited States
-
AGO Study GroupEssex Pharma GmbH; MedServ. GmbH, WiesbadenCompletedCervical Cancers | Cancer of the Ovary Treated as 2nd Line Therapy | Muellerian Mixed Tumours | Tumours of the Uterus | Non-Epithelial Ovarian TumoursGermany
-
Gynecologic Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedStage III Uterine Corpus Cancer | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous Carcinoma | Endometrial Endometrioid Adenocarcinoma, Variant With Squamous DifferentiationUnited States
-
University of WashingtonGlaxoSmithKlineRecruitingAnatomic Stage III Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Pancreatic Carcinoma | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Unresectable Pancreatic... and other conditionsUnited States
-
Johns Hopkins UniversityNational Human Genome Research Institute (NHGRI)CompletedHuntington Disease | Hereditary Cancer | Hereditary Breast and Ovarian Cancer | Hereditary Non-polyposis Colon Cancer | Hereditary Non-Polyposis Colorectal Cancer SyndromeUnited States
-
Hebei Medical University Fourth HospitalNot yet recruiting
-
The Netherlands Cancer InstituteRecruitingFallopian Tube Carcinoma | Peritoneal Cancer | FIGO Stage III Ovarian CancerNetherlands
-
Sutro Biopharma, Inc.Active, not recruitingOvarian Cancer | Fallopian Tube Cancer | Ovarian Carcinoma | Ovary Cancer | Primary Peritoneal CarcinomaUnited States